Use the Back button in your browser to see the other results of your search or to select another record.
Comparative effectiveness of Chuna manipulative therapy for non-acute lower back pain: a multi-center, pragmatic, randomized controlled trial |
Park S-Y, Hwang E-H, Cho J-H, Kim K-W, Ha I-H, Kim M-R, Nam K, Lee M-H, Lee J-H, Kim N, Shin B-C |
Journal of Clinical Medicine 2020 Jan;9(1):144 |
clinical trial |
8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Current evidence on the effectiveness and safety of Chuna manipulative therapy (CMT) for managing non-acute lower back pain (LBP) is insufficient. We investigated the comparative effectiveness and safety of CMT, a Korean style of manipulation, plus usual care (UC) compared to UC alone for non-acute LBP. We conducted a parallel, two-armed, multi-centered, assessor blinded, pragmatic, randomized controlled trial at four major Korean medical hospitals. Overall, 194 patients were randomly allocated to either CMT+UC (n = 97) or UC alone (n = 97), for six weeks of treatment and six months follow-up. The primary outcome was measured using the numerical rating scale (NRS) of LBP intensity at 7 weeks. Secondary outcomes included NRS of leg pain, Oswestry Disability Index (ODI) for functional disability, patient global impression of change (PGIC) scale, and safety. A total of 194 patients were included in the intention-to-treat analysis, and 174 patients provided complete data for the primary outcome. At 7 weeks, clinically significant differences between groups were observed in the NRS of LBP (CMT+UC -3.02 +/- 1.72, UC -1.36 +/- 1.75, p < 0.001), ODI scores (CMT+UC -5.65 +/- 4.29, UC -3.72 +/- 4.63, p = 0.003), NRS of leg pain (CMT+UC -2.00 +/- 2.33, UC -0.44 +/- 1.86, p < 0.0001), and PGIC (CMT+UC -0.28 +/- 0.85, UC 0.01 +/- 0.66, p = 0.0119). Mild to moderate safety concerns were reported in 21 subjects. CMT+UC showed higher effectiveness compared to UC alone in patients with non-acute LBP in reducing LBP and leg pain and in improving function with good safety results using a powered sample size and including mid-term follow-up.
|